![](/img/cover-not-exists.png)
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial
S. Petersenn,L. R. Salgado,J. Schopohl,L. Portocarrero-Ortiz,G. Arnaldi…Volume:
57
Language:
english
Journal:
Endocrine
DOI:
10.1007/s12020-017-1316-3
Date:
July, 2017
File:
PDF, 1.07 MB
english, 2017